1. Home
  2. ASLE vs IRWD Comparison

ASLE vs IRWD Comparison

Compare ASLE & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AerSale Corporation

ASLE

AerSale Corporation

HOLD

Current Price

$6.95

Market Cap

290.0M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.59

Market Cap

251.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASLE
IRWD
Founded
2008
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
290.0M
251.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
ASLE
IRWD
Price
$6.95
$3.59
Analyst Decision
Hold
Buy
Analyst Count
2
5
Target Price
$7.00
$5.34
AVG Volume (30 Days)
417.3K
2.3M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.11
0.18
Revenue
$339,090,000.00
$338,987,000.00
Revenue This Year
$1.35
N/A
Revenue Next Year
$19.09
$4.01
P/E Ratio
$62.29
$20.22
Revenue Growth
N/A
N/A
52 Week Low
$5.56
$0.53
52 Week High
$9.12
$5.13

Technical Indicators

Market Signals
Indicator
ASLE
IRWD
Relative Strength Index (RSI) 59.59 61.99
Support Level $6.33 $3.50
Resistance Level $7.11 $3.80
Average True Range (ATR) 0.16 0.33
MACD 0.11 -0.05
Stochastic Oscillator 82.50 58.96

Price Performance

Historical Comparison
ASLE
IRWD

About ASLE AerSale Corporation

AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: